SYNOPSIS A pair of siblings, both of whom had neonatal thrombocytopenic purpura, are described. During the first pregnancy, the mother was given chlorothiazide and the implications of this therapy are considered. At the end of the second pregnancy a platelet iso-antibody was detected in the maternal serum. The possible reason for not detecting this antibody in the serum of the second child is considered.
Evidence of the transplacental transfer of red cell antibodies is well established, but proof that platelet antibodies behave in the same way has not been so quickly forthcoming despite the fact that thrombocytopenic purpura in the newborn was reported as long ago as 1873 by Dohrn. Nevertheless, since 1950, with some improvement of techniques for the detection of platelet antibodies, reports have come from various workers describing the presence of such antibodies in the sera of infants suffering from neonatal thrombocytopenic purpura, and also in the sera of their mothers. Cases fall into two groups: those in which the mother suffers from idiopathic thrombocytopenic purpura and transmits her platelet auto-antibody to her foetus, and those in which the mother is apparently normal, but possesses a platelet iso-antibody, developed presumably as a result of pregnancy or transfusion. In either case, the effect on the child is the same, there being thrombocytopenia, with or without purpura, which disappears as the amount of maternal platelet antibody diminishes in the child's circulation.
In this paper, we wish to report the case histories of two brothers who each became purpuric shortly after birth and later died. Menzies (1964) has already referred to the first of these two children in his paper on a 'Controlled trial of chlorothiazide in treatment of early pre-eclampsia'. The serum of the second of these two children and of the mother were examined for possible presence of platelet antibodies, Received for publication 23 December 1964. but such tests were not performed during or after the first pregnancy.
Perhaps as important as the detection of platelet antibodies in the second pregnancy was the fact that the mother received chlorothiazide for hypertension during the first pregnancy. Recently, Rodriguez, Leikin, and Hiller (1964) Significance ofplatelet antibodies in neonatal thrombocytopenic purpura affecting a pair of siblings Investigations shortly after birth showed haemoglobin 119 g./l00 ml. (81 %); W.B.C. 17,000/c.mm. with a normal differential count; prothrombin time 15-5 seconds, control 11-6 seconds; blood group 0 Rhesus positive, direct antiglobulin (Coombs) test negative; platelets less than 1,000/c.mm.; serum bilirubin 2-9 mg./100 ml.
Potassium menaphthosulphate (Vikastab), 3 mg., was given on the day of delivery and steroid therapy was begun at two hours. At 12 hours, because of increasing irritability and the possibility of intracranial haemorrhage, he was given a transfusion of 95 ml. of fresh donor blood.
On the second day, no platelets could be seen in the peripheral blood, either in a stained smear or in a wet preparation. Severe respiratory distress with cyanosis was now present, there was marked irritability on handling, and the fontanelle tension was increased. Subdural taps were negative, but lumbar puncture revealed a grossly bloodstained cerebrospinal fluid under pressure, the supematant being deeply xanthochromic.
Respirations subsequently became increasingly laboured and the infant died, aged 53 hours.
NECROPSY FINDINGS (DR. W. G. SPECTOR) There were numerous subserous haemorrhages over the lungs, heart, and intestines with some bleeding into the renal pelvis and bladder mucosa. There was extensive bilateral haemorrhage over the surface of the brain excavating the temporo-parietal lobes on the left-hand side. The lungs were congested and sank in formol saline; on microscopy they showed massive intra-alveolar haemorrhage, oedema, and very extensive hyaline membrane formation. No megakaryocytes could be seen in a smear of tibial marrow taken within 10 minutes of the infant's death. The spleen was slightly enlarged, dark and firm. CASE 2 Paul A., the second child of Mrs. A. (see Fig. 1 ), was born on 19 August 1963, following a normal pregnancy and delivery at 37 weeks and weighed 7 lb. 7 oz. (3-380 kg.). In the first hour after delivery, he rapidly developed extensive purpura and subcutaneous ecchymoses. Later, there was slight bleeding per rectum. Large fontanelle-like cranial defects were present over the temporo-parietal areas above both ears. The initial investigations were: haemoglobin 20-7 g./100 ml. (140%), platelets 42,000/c.mm., bleeding time 7 minutes, clotting time 2 minutes 2 seconds.
Steroid therapy was commenced at once, using parenteral hydrocortisone, 100 mg. daily. Prednisolone, 20 mg., was substituted on the eighth day and the dosage gradually reduced to 7-5 mg./day. The platelet count, after dropping to 22,000/c.mm. on the third day, varied from 60,000 to 200,000/c.mm. The only possible further episode of haemorrhage was an unexplained swelling of the left calf on the fifth day, which subsided spontaneously. At no time was the fontanelle tension increased, but examination of the cerebrospinal fluid on the ninth day showed a pale straw-coloured fluid with a protein content of 106 mg./100 ml. suggesting previous intracranial haemorrhage.
The skull circumference, 36 cm. at birth, increased steadily until it was 37-5 cm. on the nineteenth day, and on the twenty-second day burr hole ventriculography . Dausset and Brecy (1958) was used by K.L.G.G. and W.J.J., platelets being obtained from healthy blood donors, the mother or father as indicated.
RESULTS
Details of platelet counts are recorded in the case histories.
Platelet agglutinins were not detected either in the serum of the mother or of Paul A. Simon A. was not tested. Platelets of healthy donors, of the mother, and of the father were used in each case.
Antiglobulin consumption tests were performed and results showed the presence of antibodies in the mother's serum to the father's platelets and to pooled donor platelets, but not to her own platelets (Table I) . 
